Almac Pharma Services’ President and Managing Director, John McQuaid, talks about CDMO industry trends
and the most recent expansion at its headquarters campus.
Raja will work closely with Almac Group’s corporate social responsibility and procurement teams to develop business improvement initiatives across the globe.
Achievements from the KTP partnership include the build and installation of flow rigs and successful delivery of multiple projects at 100’s of kgs scale.
€420,000 grant enables exploration of emerging enzymes such as ene-reductase (ERED) and carboxylic acid reductase (CAR) enzymes in continuous flow reactors.
High-res NMR is a key enabling technology that delivers advanced characterization and purity assessment abilities in line with regulatory requirements.
Almac Clinical Services to provide clinical trial services from protocol through to patient delivery, and Almac Sciences will provide analytical support.